search
Back to results

Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1

Primary Purpose

Cocaine-Related Disorders

Status
Unknown status
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Cocaine (IV)
Sponsored by
National Institute on Drug Abuse (NIDA)
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cocaine-Related Disorders

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Cocaine dependent, non treatment seeking individuals Exclusion Criteria: Please contact site directly for details.

Sites / Locations

  • UCLA Integrated Substance Abuse Program
  • University of Texas Health Science Center

Outcomes

Primary Outcome Measures

Cocaine craving
Cocaine related high

Secondary Outcome Measures

Full Information

First Posted
June 18, 2002
Last Updated
January 10, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00040066
Brief Title
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
Official Title
Development of Human Laboratory Study Model of Cocaine Relapse Prevention
Study Type
Interventional

2. Study Status

Record Verification Date
September 2004
Overall Recruitment Status
Unknown status
Study Start Date
May 2002 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
August 2003 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
National Institute on Drug Abuse (NIDA)

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.
Detailed Description
The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cocaine-Related Disorders

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
Double
Enrollment
32 (false)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Cocaine (IV)
Primary Outcome Measure Information:
Title
Cocaine craving
Title
Cocaine related high

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cocaine dependent, non treatment seeking individuals Exclusion Criteria: Please contact site directly for details.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John Roache, Ph.D.
Organizational Affiliation
National Institute on Drug Abuse (NIDA)
Official's Role
Principal Investigator
Facility Information:
Facility Name
UCLA Integrated Substance Abuse Program
City
Los Angeles
State/Province
California
ZIP/Postal Code
90024
Country
United States
Facility Name
University of Texas Health Science Center
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78284
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1

We'll reach out to this number within 24 hrs